1.
Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.
2.
3.
4.
5.
6.
7.
Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study.
The impact of reimbursement criteria on the appropriateness of 'statin' prescribing.
Le medicament du mois. Rosuvastatine (Crestor). ; Drug of the month. Rosuvastatin (Crestor)
De l'utilité d'une consultation conjointe de gynécologie- endocrinologie pédiatrique : étude rétrospective des motifs de consultation et approche pratique ; The usefulness of combi...
Risque de restenose et d'evenements cardiaques apres angioplastie coronaire chez le patient diabetique: reduction par des approches pharmacologiques systemiques. ; Incidence of res...